Leukaemia:Neurological Involvement
in Handbk of Clinical Neurology, Vinkin PJ & Bruyn GW, Ed, North-Holland Publ Co, Amsterdam 39:1, Yuill,G.M., 1980
Chronic Meningitis
NEJM 385:930-936, Aksamit, A.J., 2021
Toxoplasmosis in HIV-Infected Patients
www.UptoDate.com, May, Gandhi, R.T., 2019
Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017
CNS Cryptococcosis in HIV
eMedicine.com Nov 2017, Gliksman, F.J. & Singh, N.N., 2017
Histoplasmosis in Patient with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS)
Medicine 93:11-18, Myint, T.,et al, 2014
Nocardiosis of the Central Nervous System
Medicine 93:19-32, Anagnostou, T.,et al, 2014
Combination Antifungal Therapy for Cryptococcal Meningitis
NEJM 368:1291-1302, Day, J.,et al, 2013
Human Herpes 6 Virus Encephalitis Complicating Allogeneic Hematopoietic Stem Cell Transplantation
Neurol 80:1494-1500, Bhanushali, M.,et al, 2013
Clinicopathologic Conference,Brain Abscess due to Toxoplasma and Advanced HIV Infection
NEJM 366:745-755, Case 6-2012, 2012
Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
Clin Lymphoma Myeloma Leuk 12:164-179, Lopes da Silva, R., 2012
Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009
Spectrum and Prognosis of Neurologic Complications After Hematopoietic Transplantation
Neurol 67:1990-1997, Denier,C.,et al, 2006
Progressive Multifocal Leucoencephalopathy: Progress in the AIDS Era
JNNP 69:569-571, Manji,H. & Miller,R.F., 2000
Fungal Meningitis
Semin Neurol 20:307-322, Gottfredsson, M. & Perfect J.R., 2000
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Cytomegalovirus Encephalitis
Ann Int Med 125:577-578, Arribas,J.R.,et al, 1996
Central Nervous System Lesions in Adult Liver Transplant Recipients:Clinical Review with Implications for Management
Medicine 73:110-118, Singh,N.,et al, 1994
Tuberculous Meningitis in Patients Infected with the Human Immunodeficiency Virus
NEJM 326:668-672, 7031992., Berenguer,J.,et al, 1992
Toxoplasma Encephalitis in Patients with the Acquired Immunodeficiency Syndrome
Medicine 71:224-239, Renold,C.,et al, 1992
Toxoplasmosis of the Central Nervous System in the Acquired Immunodeficiency Syndrome
NEJM 327:1643-1648, Porter,S.B.&Sande,M.A., 1992
Cerebrovascular Disease in AIDS:A Case-Control Study
AIDS 4:239-244, Berger,J.R.,et al, 1990
AIDS and the Nervous System
JAMA 261:2396-2399, Dalakas,M.,et al, 1989
Retroviruses in the Nervous System:Neurological Involv in AIDS
Neurological Disorders Assoc with HTLV-I, NIH Symposium (Suppl) , Ann Neurol 23:S1-S2178., , 1988
Treatment of Infections Associated with Human Immunodeficiency Virus
NEJM 318:1439-1448, Glatt,A.E.,et al, 1988
Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987
Neurologic Manifestations of Infection with Human Immunodeficiency Virus, Clinical Features & Pathogenesis
Ann Int Med 107:383-391, Gabuzda,D.H.,et al, 1987
Toward Simpler, Safer Treatment of Cryptococcal Meningitis
NEJM 386:1179-1181, Moosa, M.Y.S. & Lessells, R.J., 2022
An Unexpected Response to Therapy in a Patient with HIV and Focal Seizures
Neurol 97:1084-1089, Chishimba, L.,et al, 2021
Clinicopathologic Conference, HIV Type 2 Infection & Cerebral Toxoplasmosis
NEJM 383:859-866, Case 27-2020, 2020
Clinicopathologic conference, Cryptococcal meningoencephalitis and advanced HIV infection
NEJM 383:2572-2580, Case 40-2020, 2020
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
NEJM 380:1597-1605, Cortese, I.,et al, 2019
Clinicopathologic Conference, Human Herpesvirus 6-Related Meningoencephalitis
NEJM 378:659-669, Case 5-2018, 2018
Pediatric HIV Infection: Classification, Clinical Manifestations, and Outcome
www.UptoDate.com, June, Gillespie, S.L., 2018
Clinicopathologic Conference Cryptococcal Meningitis in a Patient with Chronic HIV Infection
NEJM 376:1065-1071, Case 8-2017, 2017
Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016
Holmes Tremor
Neurol 86:931-938, Raina, G.B.,et al, 2016
Cryptococcal Meningoencephalitis in a Patient with Multiple Sclerosis Treated with Fingolimod
JAMA Neurol 72:1203-1205, Zhan, Y.,et al, 2015
Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, IFe Acquired Immunodeficiency Syndrome
Adams & Victors Principles of Neurology, Chp 33, pg 758, Ropper, A.H.,et al, 2014
Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Opportunistic Infections and Neoplasms of CNS in AIDS
Adams & Victors Principles of Neurology, Chp 33, pg 761, Ropper, A.H.,et al, 2014
Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Cryptococcosis (Torulosis European-Blastomycosis.
Adams & Victors Principles of Neurology, Chp 32, pg 731, Ropper, A.H.,et al, 2014
Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Toxoplasmosis
Adams & Victors Principles of Neurology, Chp 31, pg 734, Ropper, A.H.,et al, 2014
CNS-Immune Reconstitution Inflammatory Syndrome in the Setting of HIV Infection, Part 1: Overview and Discussion of Progressive Multifocal Leukoencephalopathy-Immune Reconstitution Inflammatory Syndrome and Cryptococcal-Immune Reconstitution Inflammatory Syndrome
AJNR 34:1297-1307, Post, M.J.D.,et al, 2013
Headache in Transplant Patients
www.medlink.com, Aug, Lai, T.H., 2011
The stages and natural history of HIV infection
Up to date: Sept, Bartlett, J.G.,et al, 2010
Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009
Reemergence of PML in Natalizumab-Treated Patients--New Cases, Same Concerns
NEJM 361:1041-1043, Major,E., 2009
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009